vs

Side-by-side financial comparison of Commercial Vehicle Group, Inc. (CVGI) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($225.6M vs $154.8M, roughly 1.5× Commercial Vehicle Group, Inc.). On growth, Organogenesis Holdings Inc. posted the faster year-over-year revenue change (78.1% vs -5.2%). Organogenesis Holdings Inc. produced more free cash flow last quarter ($34.8M vs $8.7M). Over the past eight quarters, Organogenesis Holdings Inc.'s revenue compounded faster (43.2% CAGR vs -10.8%).

WABCO Holdings, Inc. was a U.S.-based provider of electronic braking, stability, suspension and transmission automation systems for heavy-duty commercial vehicles. In 2007, the Vehicle Control Systems was spun off as WABCO Holdings Inc., an American provider of electronic braking, stability, suspension and transmission automation systems for heavy-duty commercial vehicles. Their products are present in many commercial vehicles such as trucks, buses, trailers and off-highway vehicles but they ...

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

CVGI vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.5× larger
ORGO
$225.6M
$154.8M
CVGI
Growing faster (revenue YoY)
ORGO
ORGO
+83.3% gap
ORGO
78.1%
-5.2%
CVGI
More free cash flow
ORGO
ORGO
$26.0M more FCF
ORGO
$34.8M
$8.7M
CVGI
Faster 2-yr revenue CAGR
ORGO
ORGO
Annualised
ORGO
43.2%
-10.8%
CVGI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CVGI
CVGI
ORGO
ORGO
Revenue
$154.8M
$225.6M
Net Profit
$43.7M
Gross Margin
9.7%
Operating Margin
-1.2%
28.1%
Net Margin
19.4%
Revenue YoY
-5.2%
78.1%
Net Profit YoY
469.5%
EPS (diluted)
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CVGI
CVGI
ORGO
ORGO
Q4 25
$154.8M
$225.6M
Q3 25
$152.5M
$150.9M
Q2 25
$172.0M
$101.0M
Q1 25
$169.8M
$86.7M
Q4 24
$163.3M
$126.7M
Q3 24
$171.8M
$115.2M
Q2 24
$193.7M
$130.2M
Q1 24
$194.6M
$110.0M
Net Profit
CVGI
CVGI
ORGO
ORGO
Q4 25
$43.7M
Q3 25
$-7.1M
$21.6M
Q2 25
$-4.8M
$-9.4M
Q1 25
$-4.3M
$-18.8M
Q4 24
$7.7M
Q3 24
$9.5M
$12.3M
Q2 24
$-1.6M
$-17.0M
Q1 24
$2.9M
$-2.1M
Gross Margin
CVGI
CVGI
ORGO
ORGO
Q4 25
9.7%
Q3 25
10.5%
Q2 25
11.4%
Q1 25
10.5%
72.6%
Q4 24
8.0%
75.5%
Q3 24
9.6%
76.7%
Q2 24
10.6%
77.6%
Q1 24
11.9%
73.9%
Operating Margin
CVGI
CVGI
ORGO
ORGO
Q4 25
-1.2%
28.1%
Q3 25
-0.7%
13.7%
Q2 25
0.5%
-12.5%
Q1 25
0.8%
-30.9%
Q4 24
-3.2%
8.1%
Q3 24
-0.6%
5.4%
Q2 24
0.5%
-10.7%
Q1 24
2.3%
-3.5%
Net Margin
CVGI
CVGI
ORGO
ORGO
Q4 25
19.4%
Q3 25
-4.6%
14.3%
Q2 25
-2.8%
-9.3%
Q1 25
-2.5%
-21.7%
Q4 24
6.1%
Q3 24
5.5%
10.7%
Q2 24
-0.8%
-13.1%
Q1 24
1.5%
-1.9%
EPS (diluted)
CVGI
CVGI
ORGO
ORGO
Q4 25
$0.31
Q3 25
$0.11
Q2 25
$-0.10
Q1 25
$-0.17
Q4 24
$0.05
Q3 24
$0.09
Q2 24
$-0.05
$-0.13
Q1 24
$0.09
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CVGI
CVGI
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$93.7M
Total DebtLower is stronger
$104.9M
Stockholders' EquityBook value
$133.4M
$300.1M
Total Assets
$391.7M
$598.7M
Debt / EquityLower = less leverage
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CVGI
CVGI
ORGO
ORGO
Q4 25
$93.7M
Q3 25
$63.7M
Q2 25
$73.1M
Q1 25
$110.0M
Q4 24
$135.6M
Q3 24
$94.3M
Q2 24
$89.9M
Q1 24
$88.6M
Total Debt
CVGI
CVGI
ORGO
ORGO
Q4 25
$104.9M
Q3 25
$108.2M
Q2 25
$118.2M
Q1 25
$117.4M
Q4 24
$135.5M
Q3 24
$128.8M
$62.3M
Q2 24
$142.0M
$63.8M
Q1 24
$155.7M
$65.2M
Stockholders' Equity
CVGI
CVGI
ORGO
ORGO
Q4 25
$133.4M
$300.1M
Q3 25
$136.5M
$255.1M
Q2 25
$142.6M
$233.2M
Q1 25
$136.7M
$242.9M
Q4 24
$135.6M
$262.9M
Q3 24
$179.3M
$278.5M
Q2 24
$169.6M
$263.5M
Q1 24
$175.5M
$278.0M
Total Assets
CVGI
CVGI
ORGO
ORGO
Q4 25
$391.7M
$598.7M
Q3 25
$400.3M
$509.8M
Q2 25
$429.8M
$461.1M
Q1 25
$419.8M
$467.4M
Q4 24
$424.6M
$497.9M
Q3 24
$495.3M
$446.3M
Q2 24
$503.2M
$443.2M
Q1 24
$509.2M
$458.5M
Debt / Equity
CVGI
CVGI
ORGO
ORGO
Q4 25
0.79×
Q3 25
0.79×
Q2 25
0.83×
Q1 25
0.86×
Q4 24
1.00×
Q3 24
0.72×
0.22×
Q2 24
0.84×
0.24×
Q1 24
0.89×
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CVGI
CVGI
ORGO
ORGO
Operating Cash FlowLast quarter
$12.3M
$39.4M
Free Cash FlowOCF − Capex
$8.7M
$34.8M
FCF MarginFCF / Revenue
5.6%
15.4%
Capex IntensityCapex / Revenue
2.3%
2.1%
Cash ConversionOCF / Net Profit
0.90×
TTM Free Cash FlowTrailing 4 quarters
$34.0M
$-24.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CVGI
CVGI
ORGO
ORGO
Q4 25
$12.3M
$39.4M
Q3 25
$-1.7M
$3.1M
Q2 25
$18.9M
$-32.9M
Q1 25
$15.2M
$-19.9M
Q4 24
$-26.6M
$10.9M
Q3 24
$-17.1M
$8.7M
Q2 24
$12.6M
$4.7M
Q1 24
$-2.4M
$-10.2M
Free Cash Flow
CVGI
CVGI
ORGO
ORGO
Q4 25
$8.7M
$34.8M
Q3 25
$-3.5M
$844.0K
Q2 25
$17.4M
$-36.5M
Q1 25
$11.4M
$-23.6M
Q4 24
$-30.6M
$7.6M
Q3 24
$-20.3M
$6.1M
Q2 24
$6.4M
$2.9M
Q1 24
$-7.4M
$-12.4M
FCF Margin
CVGI
CVGI
ORGO
ORGO
Q4 25
5.6%
15.4%
Q3 25
-2.3%
0.6%
Q2 25
10.1%
-36.1%
Q1 25
6.7%
-27.2%
Q4 24
-18.7%
6.0%
Q3 24
-11.8%
5.3%
Q2 24
3.3%
2.2%
Q1 24
-3.8%
-11.3%
Capex Intensity
CVGI
CVGI
ORGO
ORGO
Q4 25
2.3%
2.1%
Q3 25
1.2%
1.5%
Q2 25
0.9%
3.6%
Q1 25
2.2%
4.2%
Q4 24
2.4%
2.7%
Q3 24
1.9%
2.2%
Q2 24
3.2%
1.4%
Q1 24
2.6%
2.0%
Cash Conversion
CVGI
CVGI
ORGO
ORGO
Q4 25
0.90×
Q3 25
0.14×
Q2 25
Q1 25
Q4 24
1.43×
Q3 24
-1.79×
0.71×
Q2 24
Q1 24
-0.80×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CVGI
CVGI

Global Seating$70.7M46%
Global Electrical Systems$49.7M32%
Trim Systems And Components$34.4M22%

ORGO
ORGO

Segment breakdown not available.

Related Comparisons